João Nuno Moreira (J N Moreira, João N Moreira)

Scopus Author ID Ciência ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Venues

Pharmaceuticals (Basel, Switzerland)

Cancers

Neuro-oncology

Drug delivery and translational research

Faculty of Pharmacy, University of Coimbra

Faculty of Pharmacy, University of Coimbra and Faculty of Medicine, University of Alberta (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Faculty of Pharmacy, University of Coimbra

Portugal

Assistant Professor with Habilitation

Center for Neurosciences and Cell Biology, University of Coimbra Jan 01 1996

Portugal

Principal Investigator

Education History

Faculty of Pharmacy, University of Coimbra and Faculty of Medicine, University of Alberta - Mar 18 2002

Portugal

PHD

Faculty of Sciences and Technology, University of Coimbra - Apr 28 1995

Portugal

MSC

Publications

Liliana Santos, Francesca Tomatis, Hugo R S Ferreira, Sara F F Almeida, Edward Ciputra, José Sereno, Rui Almeida, Paulo Teixeira, Ana Sofia Ribeiro, João Nuno Moreira, Ana Paula Silva, Lino S Ferreira, Antero José Abrunhosa, Célia M Gomes
ENPP1 induces blood-brain barrier dysfunction and promotes brain metastasis formation in HER2-positive breast cancer. Neuro-oncology (2024)
Ana Catarina Silva, João Nuno Moreira, José Manuel Sousa Lobo
Current Insights on Lipid-Based Nanosystems 2023. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
A C Correia, João Nuno Moreira, J M Sousa Lobo, Ana Catarina Silva
Design of experiment (DoE) as a quality by design (QbD) tool to optimize formulations of lipid nanoparticles for nose-to-brain drug delivery. Expert opinion on drug delivery (2023)
Ana Catarina Silva, João Nuno Moreira, José Manuel Sousa Lobo
Current Insights on Lipid-Based Nanosystems 2023. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Ângela Valério-Fernandes, Nuno A Fonseca, Nélio Gonçalves, Ana F Cruz, Marta I Pereira, Ana C Gregório, Vera Moura, Ana F Ladeirinha, Ana Alarcão, Joana Gonçalves, Antero José Abrunhosa, Joana B Melo, Lina Carvalho, Sérgio Simões, João Nuno Moreira
Nucleolin Overexpression Predicts Patient Prognosis While Providing a Framework for Targeted Therapeutic Intervention in Lung Cancer. Cancers 14 (9) (2022)
Ana Catarina Silva, João Nuno Moreira, José Manuel Sousa Lobo
Editorial-Current Insights on Lipid-Based Nanosystems. Pharmaceuticals (Basel, Switzerland) 15 (10) (2022)
Rui Lopes, Kevin Shi, Nuno A Fonseca, Adelina Gama, José S Ramalho, Luís Almeida, Vera Moura, Sérgio Simões, Bruce Tidor, João Nuno Moreira
Modelling the impact of nucleolin expression level on the activity of F3 peptide-targeted pH-sensitive pegylated liposomes containing doxorubicin. Drug delivery and translational research (2021)
Ana F Cruz, Mariana B Caleiras, Nuno A Fonseca, Nélio Gonçalves, Vera M Mendes, Susana F Sampaio, Vera Moura, Joana B Melo, Ramiro D Almeida, Bruno Manadas, Sérgio Simões, João Nuno Moreira
The Enhanced Efficacy of Intracellular Delivery of Doxorubicin/C6-Ceramide Combination Mediated by the F3 Peptide/Nucleolin System Is Supported by the Downregulation of the PI3K/Akt Pathway. Cancers 13 (12) (2021)
Cláudia Pina Costa, Sandra Barreiro, João Nuno Moreira, Renata Silva, Hugo Almeida, José Manuel Sousa Lobo, Ana Catarina Silva
In Vitro Studies on Nasal Formulations of Nanostructured Lipid Carriers (NLC) and Solid Lipid Nanoparticles (SLN). Pharmaceuticals (Basel, Switzerland) 14 (8) (2021)
Ana C Gregório, Manuela Lacerda, Paulo Figueiredo, Sérgio Simões, Sérgio Dias, João Nuno Moreira
Therapeutic Implications of the Molecular and Immune Landscape of Triple-Negative Breast Cancer. Pathology oncology research : POR 24 (4) (2017)

João Nuno Moreira.css-eqlu8i{font-size:small;padding-left:4px;} (J N Moreira, João N Moreira)

Publication Activity (10 Years)

Top Topics

Top Venues

João Nuno Moreira (J N Moreira, João N Moreira)